BiotechTV

قناة - البرامج: ‫٥‬

علوم حياة

علوم حياة

يتم التحديث كل أسبوعين
علوم حياة

علوم حياة

٢٠ فبراير
علوم حياة

علوم حياة

١٩‏/١٢‏/٢٠٢٥
علوم حياة

علوم حياة

٣٠‏/٠٦‏/٢٠٢٥
علوم حياة

علوم حياة

٢ فبراير

قبل ٤ أيام

Episode 35: INITIATE Ventures' Jessica Owens

Jessica Owens discusses the many experiences she has had in her career, including working on the venture side at Kleiner Perkins and Versant Ventures and on the operating side at Genomic Health and Grail. She highlights the value of VCs being able to understand how operators like CEOs think, and describes the type of investing INITIATE focuses on.

قبل ٤ أيام

-

١ س ٩ د
٢٠ فبراير

Protagonist Therapeutics has two medicines in front of FDA right now - we discuss the expertise in peptide based drug development that has enabled them to get to this point

CEO Dinesh Patel and Chief Discovery Officer Ashok Bhandari walk us through the company's R&D expertise, and we discuss programs covering IL-23, IL-17, a hepcidin mimetic, and obesity medicines.

٢٠ فبراير

-

٢٦ من الدقائق
٩ فبراير

Episode 34: General Atlantic's Brett Zbar

Brett Zbar describes his early career, including working at Aisling Capital and Foresight Capital, and now managing the healthcare strategy at General Atlantic. He describes how he sees the difference between private equity and venture capital, and discusses which themes in biotech and healthcare appeal to him today.

٩ فبراير

-

١ س ٧ د
١٩ فبراير

NewLimit is using epigenetic reprogramming to bring cells back to a younger and healthier state, thus tackling age related disease

Co-Founder & President Jacob Kimmel describes the science behind how this works, and the enormous amount of work that goes into choosing which transcription factors to target. The company is currently in IND enabling studies.

١٩ فبراير

-

١١ من الدقائق
١٢ فبراير

Analyst Thursdays: Mizuho Senior Biotech Analyst Graig Suvannavejh shares his take on three key biotech trials that are scheduled to read out soon, and one that recently happened

He discusses upcoming readouts for IDEAYA Biosciences, Ocular Therapeutix (how it might affect EyePoint), and Palvella Therapeutics. Plus, his take on the recent Corvus atopic dermatitis data.

١٢ فبراير

-

١٩ من الدقائق
١٩ فبراير

Cambridge, UK based Arecor uses formulation and development expertise to improve the profile of medicines - leveraging this, the company believes it has its own best in class insulin

CEO Sarah Howell discusses three key aspects of the business: helping with reformulation, its own proprietary insulin products, and developing oral peptides like GLPs.

١٩ فبراير

-

٢٦ من الدقائق
١٨ فبراير

Gordian Biotechnology announced that it will be using its unique large-scale in vivo screening process to help Pfizer look for new targets against obesity

Co-Founder & CSO Martin Borch Jensen describes the deal and walks us through Gordian's process that enables it to do a multiplicity of in vivo screening in months that previously would have taken years.

١٨ فبراير

-

١٠ من الدقائق
١٣ فبراير

Biotech CEOs discuss the state of the industry, what is needed to compete globally, the importance of having a patient-centric approach, and more

MassBio President & CEO Kendalle Burlin O'Connell moderates a discussion with Aurora Therapeutics CEO Ed Kaye and DaCapo Brainscience CEO Leslie Williams about being biotech leaders during this volatile time for the industry. They stress that a key to success is that everyone in the industry work together towards shared goals.

١٣ فبراير

-

٤٢ من الدقائق
١١ يناير

Episode 32: ARCH Venture Partners' Bob Nelsen

While describing his early life in Washington and formative years at the University of Chicago that led to the founding of ARCH, he shares his thoughts on leadership, risk taking, changes he thinks are need to keep the United States competitive in life sciences, and his belief in AI's promise to transform our industry.

١١ يناير

-

١ س ١٥ د
١٧ فبراير

Oxford based Infinitopes raised an additional $15.4M in a second closing of its seed round to bring the total raised to $35.1M. It will have clinical data on its cancer vaccine by the end of the year

Co-Founder & CEO Jonathan Kwok describes the company's platform, which helps it identify highly expressed and immunogenic tumor antigens, and how the lead program for oesophageal cancer will have data by the end of 2026.

١٧ فبراير

-

١٦ من الدقائق

BiotechTV covers the biotechnology sector through news, stories, podcasts, and educational videos.

موقع الويب

BiotechTV

أفضل البرامج

Episode 35: INITIATE Ventures' Jessica Owens

Protagonist Therapeutics has two medicines in front of FDA right now - we discuss the expertise in peptide based drug development that has enabled them to get to this point

Episode 34: General Atlantic's Brett Zbar

NewLimit is using epigenetic reprogramming to bring cells back to a younger and healthier state, thus tackling age related disease

Analyst Thursdays: Mizuho Senior Biotech Analyst Graig Suvannavejh shares his take on three key biotech trials that are scheduled to read out soon, and one that recently happened

Cambridge, UK based Arecor uses formulation and development expertise to improve the profile of medicines - leveraging this, the company believes it has its own best in class insulin

Gordian Biotechnology announced that it will be using its unique large-scale in vivo screening process to help Pfizer look for new targets against obesity

Biotech CEOs discuss the state of the industry, what is needed to compete globally, the importance of having a patient-centric approach, and more

Episode 32: ARCH Venture Partners' Bob Nelsen

Oxford based Infinitopes raised an additional $15.4M in a second closing of its seed round to bring the total raised to $35.1M. It will have clinical data on its cancer vaccine by the end of the year

حول

BiotechTV

أفضل البرامج

أفضل الحلقات

حول